"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to IKNA. [ FAQ on what and how to ask] For non-IKNA questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:
Headquarter: 645 Summer Street, Suite 101, Boston, MA, United States, 02210
Industry: Biotechnology, Employees: 9
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. As of July 25, 2025, Ikena Oncology, Inc. was acquired by Inmagene Biopharmaceuticals Co. Ltd.
My Watchlist
